Market Growth: The super generics market is forecasted to grow from USD 205 billion in 2023 to USD 413 billion by 2033, at a ...

India’s decentralised drug regulation system grants significant authority to State Drug Regulatory Authorities, leading to ...

The outreach agronomist with the Illinois Soybean Association says farmers that are turning to generic chemicals as a ...

This growth was, to a large degree, driven by the generics market that showed an impressive growth rate of 14 per cent by value over the last decade (CAGR 2001-2009) reaching a size of almost 90 ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

The differences between the generics industry and other pharma companies wouldn’t exist without patents – legal titles that exclude others from producing or using an invention or innovation ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

U.S. bans generic sales of obesity drug Zepbound due to supply resolution U.S. to halt generic production of Zepbound obesity ...

The top 5 biosimilar-related articles of the year highlight a significant shift in the pharmaceutical industry, with ...

After offloading a big chunk of their Japanese generics joint venture in 2020, Teva and Takeda have decided to divest the business in its entirety so they can each focus on their innovative medicines.

The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...

The act’s one-sided provisions and its disproportionate remedies cannot pass constitutional muster, argues John Cox of Barnes ...